These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 6444322

  • 1. Cytotaxin production by comedonal bacteria (Propionibacterium acnes, Propionibacterium granulosum and Staphylococcus epidermidis).
    Puhvel SM, Sakamoto M.
    J Invest Dermatol; 1980 Jan; 74(1):36-9. PubMed ID: 6444322
    [Abstract] [Full Text] [Related]

  • 2. Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism.
    Akamatsu H, Niwa Y, Kurokawa I, Masuda R, Nishijima S, Asada Y.
    Arch Dermatol Res; 1991 Jan; 283(8):524-8. PubMed ID: 1838472
    [Abstract] [Full Text] [Related]

  • 3. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum.
    Webster GF, Leyden JJ, Norman ME, Nilsson UR.
    Infect Immun; 1978 Nov; 22(2):523-9. PubMed ID: 153333
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cytotoxic activity of Propionibacterium acnes and other skin organisms.
    Allaker RP, Greenman J, Osborne RH, Gowers JI.
    Br J Dermatol; 1985 Aug; 113(2):229-35. PubMed ID: 3161535
    [Abstract] [Full Text] [Related]

  • 7. Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris.
    Knop J, Bossecker T, Kövary PM.
    Arch Dermatol Res; 1982 Aug; 274(3-4):267-75. PubMed ID: 6219635
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne.
    Białecka A, Mak M, Biedroń R, Bobek M, Kasprowicz A, Marcinkiewicz J.
    Arch Immunol Ther Exp (Warsz); 2005 Aug; 53(1):79-85. PubMed ID: 15761379
    [Abstract] [Full Text] [Related]

  • 17. Anti-P. acnes antibody in comedonal extracts.
    Knop J, Ollefs K, Frosch PJ.
    J Invest Dermatol; 1983 Jan; 80(1):9-12. PubMed ID: 6217259
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Characteristics of the Propionibacterium strains isolated from acne patients].
    Białecka A, Kasprowicz A, Kaszycki P, Marcinkiewicz J.
    Med Dosw Mikrobiol; 2004 Jan; 56(1):79-92. PubMed ID: 15524399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.